Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial: Response to David Spencer (Elsevier)

COVID-IHU #25

Version 1 du 08 Juillet 2020

Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial: Response to David Spencer (Elsevier)

Didier Raoult^1,2, Matthieu Million^1,2, Philippe Gautret^1,3, Jean-Christophe Lagier^1,2, Philippe Colson^1,2, Philippe Parola^1,3, and Jean-Marc Rolain^1,2

Lire l’article

> Retour vers la page PRE-PRINTS